The objectives of this study were: (1) to determine the prevalence and factors associated with Rhipicephalus microplus, resistant to cypermethrin and amitraz, from cattle farms in Veracruz, Mexico, and (2) to determine in vitro mortality percentages of field populations of R. microplus exposed to discriminating doses (DD) of cypermethrin and amitraz. Fifty-three populations of R. microplus were tested by bioassays using DD of cypermethrin (0.05%) and amitraz (0.0002%). The prevalence of cattle farms with R. microplus ticks that were resistant to cypermethrin and amitraz, and co-resistant to both acaricides, was 90.6, 54.7, and 47.2%, respectively. The level of cypermethrin resistance, measured as a survival percentage, was higher as compared to amitraz. Cattle farms with ≤50 animals (odds ratio [OR] = 3.84, 95% confidence interval [CI] = 1.07–13.70, P = 0.038) and a stocking density of >1 animal unit per ha (AU/ha) (OR = 4.21, 95% CI = 1.0–17.71, P = 0.050) had a higher probability to develop R. microplus tick populations co-resistant to both acaricides. In conclusion, there is a high prevalence of R. microplus populations on cattle farms in Veracruz, Mexico that are both resistant to cypermethrin and amitraz and co-resistant to both acaricides. The level of cypermethrin resistance is critical, and the exposition variables of ≤50 cattle and a stocking density of >1 AU/ha were factors associated with R. microplus co-resistant to both acaricides.
You have requested a machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Neither BioOne nor the owners and publishers of the content make, and they explicitly disclaim, any express or implied representations or warranties of any kind, including, without limitation, representations and warranties as to the functionality of the translation feature or the accuracy or completeness of the translations.
Translations are not retained in our system. Your use of this feature and the translations is subject to all use restrictions contained in the Terms and Conditions of Use of the BioOne website.